Agreement signedPublished 12 Nov 2025

FutureTech /
Longevity

FutureTech and Longevity Biomedical Set Business Combination

Buy side: FutureTech
Buy sideFutureTech
Target: Longevity
TargetLongevity
Longevity Biomedical Holdings Corp. · 12 Nov 2025Source
Buy side: FutureTech
Buy sideFutureTech
Target: Longevity
TargetLongevity
01 / BuyerFutureTech
02 / TargetLongevity
Source for the buyer and target: Longevity Biomedical Holdings Corp.

For the buyer and target.

“FutureTech and Longevity have agreed to a business combination through a series of transactions, including the Mergers, subject to the terms and conditions of the Merger Agreement and the other transaction agreements.”

Published 12 Nov 2025

Open the source
01

What happened

FutureTech and Longevity Biomedical, Inc. entered into a business combination agreement. The transaction includes Longevity merging with Merger Sub, with Longevity surviving as a wholly owned subsidiary of PubCo. [01]

The filing states that merger consideration is calculated as $100,000,000 less the value of certain converted stock options, divided by $10.00 per share, and payable in PubCo common stock. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Longevity Biomedical Holdings Corp.

FutureTech and Longevity Biomedical Set Business Combination

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Longevity Biomedical Holdings Corp.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.